MPERIA THERAPEUTICS
MPERIA THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2016-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.mperiathera.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
DNS.COM Peg Technic
Similar Organizations
Alternative Cellular Therapeutics
Alternative Cellular Therapeutics operates in the Biological Products.
More informations about "Mperia Therapeutics"
Mperia Therapeutics - Amorchem
Mperia Therapeutics (www.mperiathera.com) is a biotech company spun out from our CD36 programs with Dr. Ong and his collaborators from the Université de Montréal.See details»
Mperia Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Mperia Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Mperia Therapeutics Profile and History - Datanyze
Mperia Therapeutics Profile and History. Mperia Therapeutics is The CD36 Therapeutics Company focusing on macrophage-driven inflammation. The technology exploits CD36 …See details»
Mperia Therapeutics - Craft
It focuses on the development of therapeutics for CD36-mediated diseases, including heart disease, blindness, non-alcoholic steatohepatitis, and Alzheimer's. See insights on Mperia …See details»
Mperia Therapeutics Inc - LinkedIn
Mperia Therapeutics is the CD36 Therapeutics Development Company. Lead candidates applied to macrophage-driven inflammation via CD36 receptor immuno-metabolism mediation. …See details»
Mperia Therapeutics - Crunchbase Company Profile
Mperia Therapeutics is located in Montréal, Quebec, Canada. Who are Mperia Therapeutics's competitors? Alternatives and possible competitors to Mperia Therapeutics may include Watz , IntelliStem Technologies , and Quick …See details»
Mperia Therapeutics | VentureRadar
Website: http://www.mperiathera.com/ Develops CD36 therapeutic solutions targeting macrophage-driven inflammation with highly specific receptor cyclic peptides, focusing on …See details»
Mperia Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Mperia Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, , Drug:MPE-282, MPE-281, MPE-298.See details»
Mperia Therapeutics - Overview, News & Similar companies
View Mperia Therapeutics (www.mperiathera.com) location in Quebec, Canada , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Mperia Therapeutics Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Mperia Therapeutics Inc. of Westmount, QC. Get the latest business insights from Dun & Bradstreet.See details»
Mperia Therapeutics - Products, Competitors, Financials, …
Mperia Therapeutics is The CD36 Therapeutics Company focusing on macrophage-driven inflammation. The technology exploits CD36-targeting cyclic peptides and their capacity to …See details»
Mperia Therapeutics Inc. Asset Profile | Preqin
Founded in 2016 and based in Montreal, Quebec, Mperia Therapeutics Inc. is a spun-off company from Amorchem Ventures. The firm operates an immunotherapy technology that aids chronic …See details»
Mperia Therapeutics Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Mperia Therapeutics Inc. of Montréal-Ouest, QC. Get the latest business insights from Dun & Bradstreet.See details»
Mperia Therapeutics - Company Profile - Tracxn
Oct 23, 2024 · Mperia Therapeutics is developing macrophage-targeting immunotherapies via CD36 scavenger receptor. The company's immunotherapies aim to manage and ultimately …See details»
Mperia Therapeutics Adds Experts in Drug Delivery, Dry AMD ...
Dec 4, 2018 · Mperia Therapeutics is the CD36 Therapeutics Company which focuses on macrophage-driven inflammation. The technology basis resides in highly specific CD36 …See details»
Mperia Therapeutics Appoints Paul Chipperton as President and CEO
Nov 9, 2018 · Mperia Therapeutics is the CD36 Therapeutics Company which focuses on macrophage-driven inflammation. The technology basis resides in highly specific CD36 …See details»
Mperia Therapeutics - VentureRadar
Website: http://www.mperiathera.com/ Develops CD36 therapeutic solutions targeting macrophage-driven inflammation with highly specific receptor cyclic peptides, focusing on …See details»
Dr Joshua Dunaief MD, Renowned Age-Related Macular …
Mar 18, 2019 · Mperia Therapeutics is The CD36 Therapeutics Company focusing on macrophage-driven inflammation. The technology exploits CD36-targeting cyclic peptides and …See details»
People for the Ethical Treatment of Animals (PETA)
Join PETA’s Action Team to hear about protests, events, and volunteer opportunities in your area. You’ll also get tips and ideas to help you advocate for animals. Join Today! Another Orca …See details»
Personally Identifiable Information (PII) v4.0 Flashcards - Quizlet
Study with Quizlet and memorize flashcards containing terms like Which action requires an organization to carry out a Privacy Impact Assessment? A.See details»